🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Pivotal, single-dose, randomized, open-label, two-period, two-sequence, two...
Status
Completed
Location
Biopharma Services Inc.
Start Date
2025-12-17
Trial ID
NCT07393022
Treatments Being Tested
The purpose of this study is to compare the single-dose relative bioavailab...
Status
Completed
Location
MDS Pharma Services
Start Date
2003-09
Trial ID
NCT01132352
Treatments Being Tested
The purpose of this study is to compare the single-dose relative bioavailab...
Status
Completed
Location
MDS Pharma Services
Start Date
2003-09
Trial ID
NCT01131897
Treatments Being Tested
Keppra injection is approved in the US as adjunctive therapy in the treatme...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT00535392
Treatments Being Tested
The main purpose of this study is to evaluate the effectiveness of the stud...
Status
Completed
Location
110
Start Date
2011-12
Trial ID
NCT01484977
Treatments Being Tested
The study drug levetiracetam is FDA approved as an add-on medication in the...
Status
Completed
Location
Jefferson Headache Center
Start Date
2002-09
Trial ID
NCT00203216
Treatments Being Tested
The purposes of the study were to obtain further information about the opti...
Status
Completed
Location
Multiple Locations
Start Date
2000-08
Trial ID
NCT00630968
Treatments Being Tested
This study will be separated into 3 distinct phases designated as the Phase...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2015-04-21
Trial ID
NCT02348216
THe objective of this study is to compare the rate and extent of absorption...
Status
Completed
Location
CEDRA Clinical Research, LLC
Start Date
2007-01
Trial ID
NCT00859521
Treatments Being Tested
The objective of this study is to compare the rate and extent of absorption...
Status
Completed
Location
SFBC-Anapharm
Start Date
2005-10
Trial ID
NCT00849862
Treatments Being Tested